Escaned, J., Cao, D., Baber, U., Nicolas, J., Sartori, S., Zhang, Z., Dangas, G., Angiolillo, D. J., Briguori, C., Cohen, D. J., Collier, T., Dudek, D., Gibson, M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., Kunadian, V., Mehta, S., Moliterno, D. J., Ohman, E. M., Oldroyd, K. G., Sardella, G., Sharma, S. K., Shlofmitz, R., Weisz, G., Witzenbichler, B., Pocock, S., & Mehran, R. (2021). ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR. European heart journal, 42, 4624–4634. http://access.bl.uk/ark:/81055/vdc_100148637170.0x00001e